Yet many people don’t seem to recognize this—and this is a missed opportunity. Helping people to rethink side effects as ...

Moderna's vaccine chart looks quite a bit like Pfizer's did, when that vaccine was $4. Moderna's vaccine, like Pfizer's, seemed to start giving people protection from infection roughly 14 days ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

The chart below summarizes what we know so far ... About 99.5% of new cases are among the unvaccinated. Vaccine effectiveness is waning over time, which is why the US plans to roll out boosters ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s ...

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against serious COVID-19 impacts.

Clinicians and healthcare professionals should target adults aged 70 and over with underlying health conditions instead of the general population, when it comes to efforts to reduce spending and ...

A codon chart is a visual representation that ... scientists can better ensure a vaccine's effectiveness. We created this ...

A single dose of chikungunya vaccine is safe, effective, provides protection up to 2 years, and does not result in any long-term serious AEs related to vaccination.

Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week apart.